Evidence map›Paper›PMID 35619701›Full record

ArticleFrontiers in immunology2022

Skewed Cellular Distribution and Low Activation of Functional T-Cell Responses in SARS-CoV-2 Non-Seroconvertors.

Athina Kilpeläinen, Esther Jimenez-Moyano, Oscar Blanch-Lombarte, Dan Ouchi, Ruth Peña, Bibiana Quirant-Sanchez, Raul Perez-Caballero, Anna Chamorro, Ignacio Blanco, Eva Martínez-Caceres and 8 more

Abstract read
In one paragraph

Article in Frontiers in immunology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

18 authors.

Athina KilpeläinenIrsiCaixa AIDS Research Institute, Badalona, Spain.
Esther Jimenez-MoyanoIrsiCaixa AIDS Research Institute, Badalona, Spain.
Oscar Blanch-LombarteIrsiCaixa AIDS Research Institute, Badalona, Spain.
Dan OuchiIrsiCaixa AIDS Research Institute, Badalona, Spain.
Ruth PeñaIrsiCaixa AIDS Research Institute, Badalona, Spain.
Bibiana Quirant-SanchezGermans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
Raul Perez-CaballeroIrsiCaixa AIDS Research Institute, Badalona, Spain.
Anna ChamorroLluita contra la SIDA Foundation, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Ignacio BlancoGermans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
Eva Martínez-CaceresGermans Trias i Pujol Research Institute (IGTP), Badalona, Spain.
Roger ParedesIrsiCaixa AIDS Research Institute, Badalona, Spain.
Lourdes MateuInfectious Diseases Department, Hospital Universitari Germans Trias i Pujol, Badalona, Spain.
Jorge CarrilloIrsiCaixa AIDS Research Institute, Badalona, Spain.
Julià BlancoIrsiCaixa AIDS Research Institute, Badalona, Spain.
Christian BranderIrsiCaixa AIDS Research Institute, Badalona, Spain.
Marta MassanellaIrsiCaixa AIDS Research Institute, Badalona, Spain.
Bonaventura ClotetIrsiCaixa AIDS Research Institute, Badalona, Spain.
Julia G PradoIrsiCaixa AIDS Research Institute, Badalona, Spain.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The role of T cells in the control of SARS-CoV-2 infection has been underestimated in favor of neutralizing antibodies. However, cellular immunity is essential for long-term viral control and protection from disease severity. To understand T-cell immunity in the absence of antibody generation we focused on a group of SARS-CoV-2 Non-Seroconvertors (NSC) recovered from infection. We performed an immune comparative analysis of SARS-CoV-2 infected individuals stratified by the absence or presence of seroconversion and disease severity. We report high levels of total naïve and low effector CD8+ T cells in NSC. Moreover, reduced levels of T-cell activation monitored by PD-1 and activation-induced markers were observed in the context of functional SARS-CoV-2 T-cell responses. Longitudinal data indicate the stability of the NSC phenotype over three months of follow-up after infection. Together, these data characterized distinctive immunological traits in NSC including skewed cellular distribution, low activation and functional SARS-CoV-2 T-cell responses. This data highlights the value of T-cell immune monitoring in populations with low seroconversion rates in response to SARS-CoV-2 infection and vaccination.

Indexed as

COVID-19T-LymphocytesHumansImmunity, CellularSARS-CoV-2Vaccinationcellular immunityfunctionimmune activationnon-seroconvertorSARS-CoV-2T cell subsets

Identifiers

PMID35619701
PMCPMC9128381

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.